National Comprehensive Cancer Network



NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Subscribe to the NCCN Compendium
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN — Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN 3rd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend

Go back to previous page

 

 

     
 

Educational Objectives

Following this program, participants should be able to:

  • List the appropriate pathology techniques for diagnostic and prognostic modeling for patients with hematologic malignancies
  • Identify the available therapeutic options for acute lymphocytic leukemia, cutaneous T-cell lymphoma, Hodgkin’s lymphoma, chronic myelogenous leukemia, and multiple myeloma
  • Describe the role of PET in the diagnosis and management of lymphomas
  • Define best practices for the management of supportive care issues with anemia and myelodysplastic syndromes
  • Compare and contrast the risks and benefits of using ESAs in cancer care
  • Recognize the challenges presented by advanced directives with advancing disease

Last update 03/17/2008.

 
Quick Links





About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved